未经证实:男性乳腺纤维腺瘤是一种很少诊断的病变,通常与男性乳房发育症和摄入改变性激素水平的药物同时发生。在这里,我们报道了第一例男性乳腺纤维腺瘤,表现为甲状腺髓样癌。此外,我们回顾了目前男性乳腺纤维腺瘤的治疗策略.
未经证实:一名25岁的男性患者因甲状腺髓样癌(MTC)就诊于我们的外科单元。体格检查发现他的左乳房有一个未被注意的肿块。我们推迟了计划的甲状腺手术,以确定乳腺肿块是否与MTC转移有关。我们对切除的乳腺肿块进行了病理检查,并确认了纤维腺瘤的诊断。在确认乳腺肿块的良性性质后,患者接受了甲状腺全切除术和选择性颈部清扫术治疗MTC.
UNASSIGNED:根据临床表现和组织病理学结果诊断男性乳腺纤维腺瘤。男性乳腺纤维腺瘤是一种很少诊断的病变:通常与男性乳房发育和血清性激素水平改变有关。没有这些同意的情况下,这个案子的陈述更加罕见,正如我们的案例所揭示的。对于怀疑患有MTC的男性乳腺纤维腺瘤的治疗应包括延迟甲状腺手术以排除恶性肿瘤和转移的存在。
UNASSIGNED:该发现表明,即使没有这些并发症,也可以将纤维腺瘤视为男性乳腺的鉴别诊断。男性乳腺纤维腺瘤和MTC的及时诊断和有序治疗有助于改善患者预后。
UNASSIGNED: Fibroadenoma of the male breast is a rarely diagnosed lesion that often occurs concurrently with gynecomastia and the intake of medications that alter sex hormone levels. Herein, we report the first case of fibroadenoma of the male breast, presenting with medullary thyroid cancer. In addition, we reviewed the current management strategies for fibroadenoma of the male breast in the literature.
UNASSIGNED: A 25-year-old male patient presented to our surgical unit with medullary thyroid cancer (MTC). The physical examination revealed an unnoticed lump in his left breast. We delayed the planned thyroid surgery to determine whether the breast mass was associated with metastasis from MTC. We performed pathological tests from excised breast mass and confirmed the diagnosis of fibroadenoma. After confirming the benign nature of the breast mass, the patient underwent total thyroidectomy with selective neck dissection for MTC.
UNASSIGNED: Fibroadenoma of the male breast was diagnosed based on clinical presentation and histopathological findings. Fibroadenoma of the male breast is a rarely diagnosed lesion: and is often associated with gynecomastia and altered serum sex hormone level. The presentation of this case without those concurrences is even rarer, as revealed in our case. The management for suspected fibroadenoma of the male breast presented with MTC should include delaying the thyroid surgery to rule out the presence of malignancy and metastasis.
UNASSIGNED: The finding indicates that fibroadenoma can be considered a differential diagnosis in the male breast even in the absence of those concurrences. The timely diagnosis and orderly management of fibroadenoma of the male breast and MTC could help to improve the patient outcome.